Key result
Moxifloxacin analysis defines the critical concentration linked to a 10-msec QTc effect for hERG safety.
Why the study?
To characterize the exposure-response relationship and determine the safety margin associated with 10-msec QTc effects for moxifloxacin by evaluating consistency and heterogeneity across studies.
What is the exposure-response relationship and critical concentration of moxifloxacin associated with a 10-msec QTc effect across thorough QT studies?
Meta-Analysis
What is the exposure-response relationship and critical concentration of moxifloxacin associated with a 10-msec QTc effect across thorough QT studies?
Meta-analysis of thorough QT studies can effectively characterize the exposure-response relationship and estimate critical drug concentrations for hERG safety margins.
Answers are grounded in this paper and cite their sources.
Refines moxifloxacin QTc thresholds for TQT positive controls; extends single-study data with pooled precision for hERG safety margins.
One objective of meta-analysis, which synthesizes evidence across multiple studies, is to assess the consistency and investigate the heterogeneity across studies. In this project, we performed a meta-analysis on moxifloxacin (positive control in QT assessment studies) data to characterize the exposure-response relationship and determine the safety margin associated with 10-msec QTc effects for moxifloxacin based on 26 thorough QT studies submitted to the FDA. Multiple meta-analysis methods were used (including two novel methods) to evaluate the exposure-response relationship and estimate the critical concentration and the corresponding confidence interval of moxifloxacin associated with a 10-msec QTc effect based on the concentration-QTc models. These meta-analysis methods (aggregate data vs. individual participant data; fixed effect vs. random effect) were compared in terms of their precision and robustness. With the selected meta-analysis method, we demonstrated the homogeneity and heterogeneity of the moxifloxacin concentration-QTc relationship in studies. We also estimated the critical concentration of moxifloxacin that can be used to calculate the hERG safety margin of this drug.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2024) conducted a meta-analysis in QT assessment. Moxifloxacin was evaluated on Critical concentration of moxifloxacin associated with a 10-msec QTc effect. Meta-analysis of 26 thorough QT studies characterized the moxifloxacin concentration-QTc relationship and estimated the critical concentration associated with a 10-msec QTc effect for hERG safety.
Synapse has enriched 10 related papers. Consider them for comparative context: